Michael Bennet, Democrat Senator for the US state of Colorado, is making a push to protect consumers by improving the safety and quality of US drugs.
As concerns continue to mount over the safety and quality of pharmaceutical drugs sold and consumed in the USA, Senator Bennet this week introduced the Drug Safety and Accountability Act of 2010, which would enhance the ability of the Food and Drug Administration and the pharmaceutical industry to ensure US drugs are both safe and effective regardless of where they are made.
The bill would strengthen manufacturer quality standards, enhance the FDA's ability to protect Americans through improved tracking of foreign manufacturing sites, and give the FDA much-needed authority to recall potentially dangerous drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze